Overview
Pan Yang practices practicing medicine in Chongqing, China.
Their clinical expertise encompasses Angiosarcoma, Parapneumonic Pleural Effusion, Pleural Effusion, and Empyema.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Pan Yang
Is Pan Yang a top-rated expert for Angiosarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Pan Yang is classified as an Experienced expert for Angiosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Pan Yang participate in research or clinical trials?
Yes. Pan Yang has published 12 articles and abstracts on conditions like Angiosarcoma. You can view a list of Pan Yang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AngiosarcomaYang isExperienced. Learn about Angiosarcoma.
- EmpyemaYang isExperienced. Learn about Empyema.
- Lung CancerYang isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Parapneumonic Pleural Effusion
- Pleural EffusionYang isExperienced. Learn about Pleural Effusion.
- Small Cell Lung Cancer (SCLC)